Pulse Biosciences (PLSE) Share-based Compensation (2015 - 2025)

Pulse Biosciences' Share-based Compensation history runs 11 years deep, the most recent figure standing at -$16.5 million for Q4 2025.

• On a quarterly basis, Share-based Compensation fell 342.71% year-over-year to -$16.5 million in Q4 2025; TTM through Sep 2025 was $23.3 million, a 139.82% increase from a year earlier, with the FY2025 full-year figure at $27.6 million, up 52.49% from the prior year.
• Share-based Compensation fell to -$16.5 million in Q4 2025 per PLSE's latest filing, from $5.6 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $6.8 million in Q4 2024 and bottomed at -$65.2 million in Q4 2023.
• The 5-year median for Share-based Compensation is $1.8 million (2023), against an average of -$1.9 million.
• Biggest YoY gain for Share-based Compensation was 222.97% in 2025; the steepest drop was 342.71% in 2025.
• Year by year, Share-based Compensation stood at -$397000.0 in 2021, then soared by 282.12% to $723000.0 in 2022, then sank by 9124.76% to -$65.2 million in 2023, then jumped by 110.41% to $6.8 million in 2024, then slumped by 342.71% to -$16.5 million in 2025.
• Per Business Quant, the three latest PLSE Share-based Compensation figures stand at -$16.5 million (Q4 2025), $5.6 million (Q3 2025), and $5.2 million (Q2 2025).